Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-10 10:30 am Sale | 2022-12-31 | 13G | CRISPR THERAPEUTICS AG NAMEN A CRSP | Amova Asset Management Americas Inc. | 4,006,476 5.110% | -312,995![]() (-7.25%) | Filing History |
| 2023-02-03 06:10 am Sale | 2022-12-31 | 13G | CRISPR THERAPEUTICS AG NAMEN A CRSP | Sumitomo Mitsui Trust Group Inc. | 4,006,476 5.110% | -312,995![]() (-7.25%) | Filing History |
| 2022-02-14 06:05 am Purchase | 2021-12-31 | 13G | CRISPR THERAPEUTICS AG NAMEN A CRSP | Amova Asset Management Americas Inc. | 4,319,471 5.640% | 482,648![]() (+12.58%) | Filing History |
| 2022-02-11 11:19 am Sale | 2022-02-14 | 13G | CRISPR THERAPEUTICS AG NAMEN A CRSP | Capital International Investors | 3,706,004 4.800% | -558,998![]() (-13.11%) | Filing History |
| 2022-02-09 2:29 pm Purchase | 2021-12-31 | 13G | CRISPR THERAPEUTICS AG NAMEN A CRSP | ARK Investment Management LLC | 9,087,868 11.880% | 1,443,518![]() (+18.88%) | Filing History |
| 2022-02-04 06:05 am Purchase | 2021-12-31 | 13G | CRISPR THERAPEUTICS AG NAMEN A CRSP | Sumitomo Mitsui Trust Group Inc. | 4,319,471 5.640% | 482,648![]() (+12.58%) | Filing History |
| 2021-09-10 2:47 pm Sale | 2021-08-31 | 13G | CRISPR THERAPEUTICS AG NAMEN A CRSP | ARK Investment Management LLC | 7,644,350 10.030% | -2,768,626![]() (-26.59%) | Filing History |
| 2021-08-10 12:28 pm Sale | 2021-08-10 | 13G | CRISPR THERAPEUTICS AG NAMEN A CRSP | Capital International Investors | 4,265,002 5.600% | -3,361,353![]() (-44.08%) | Filing History |

